[en] A three-year-old, male, intact Jack Russel terrier was referred for severe regenerative anemia and was diagnosed with non-associated immune-mediated hemolytic anemia. Treatment was implemented according to the ACVIM guidelines (Swann et al., 2019). As no response was seen eleven days later despite two immunosuppressive drugs, intravenous immunoglobulins (IVIG, 1 g/kg) were administered. Three days later, septic shock and diffuse intravascular coagulation (DIC) developed. Echocardiography revealed pericardial effusion with cardiac tamponade and thrombus in the right atrium. Fluid analysis confirmed septic pericarditis. A pericardial drain was placed following immediate reoccurrence of the pericardial effusion. Despite a stable hematocrit for several days following IVIG administration, a decrease in hematocrit was subsequently noted and splenectomy was performed. In total, six blood transfusions were given. Two years after presentation and intensive follow-up, immunosuppressive therapy was tapered, and the dog had excellent quality of life.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
De Voogt, C.; Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
Mampaey, G.; Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
Schils, Gaëlle ; Université de Liège - ULiège > Fundamental and Applied Research for Animals and Health (FARAH) > FARAH: Médecine vétérinaire comparée ; Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
Smets, P.; Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
Stammeleer, L.; Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
Language :
Dutch
Title :
Septische pericarditis in een complex geval van niet-geassocieerde immuungemedieerde hemolytische anemie bij een jack russell terriër
Ariki H., Bandou K. (2009). Pyopericardium followed by acute progression of constrictive pericarditis. The Japanese Journal of Thoracic Surgery 62(2), 133-135.
Aronson L.R., Gregory C.R. (1995). Infectious pericardial effusion in five dogs. Veterinary Surgery 24(5), 402-407.
Bestwick J.P., Skelly B.J., Swann J.W., Glanemann B., Bexfield N., Gkoka Z., Warland J. (2022). Splenectomy in the management of primary immune-mediated hemolytic anemia and primary immune-mediated thrombocytopenia in dogs. Journal of veterinary internal medicine 36(4), 1267-1280.
Bianco D., Hardy R.M. (2009). Treatment of Evans’ syndrome with human intravenous immunoglobulin and leflunomide in a diabetic dog. Journal of the American Animal Hospital Association 45(3), 147-150.
Brincin C., Ryan T., Harris K. (2022). Gastroesophageal intussusception secondary to induction of emesis with subsequent development of septic pericardial effusion after corrective surgery. Journal of Small Animal Practice 63(1), 72-77.
Carr A.P., Panciera D.L., Kidd L. (2002). Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs. Journal of Veterinary Internal Medicine 16, 504-509.
Casamián-Sorrosal D., Fournier D., Shippam J., Woodward B., Tennant K. (2008). Septic pericardial effusion associated with pulmonary and pericardial botryomycosis in a dog. Journal of Small Animal Practice 49(12), 655-659.
Colopy S.A., Baker T.A., Muir P. (2010). Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006–2008). Journal of the American Veterinary Medical Association 236(3), 312-318.
Cook S., Cortellini S., Humm K. (2019). Retrospective evaluation of pericardial catheter placement in the management of pericardial effusion in dogs (2007–2015): 18 cases. Journal of Veterinary Emergency and Critical Care 29(4), 413-417.
Cook S., Cortellini S., Humm K. (2021). Prospective evaluation of pericardial catheter placement versus needle pericardiocentesis in the management of canine pericardial effusion. Journal of Veterinary Emergency and Critical Care 31(1), 11-17.
Farhat F., Dubreuil O., Durand P.G., Jegaden O. (2003). Constrictive pericarditis following a pyopericardium due to Staphylococcus aureus. Interactive Cardiovascular and Thoracic Surgery 2(4), 626-628.
Fuentes V.L., Long K.J., Darke P.G.G., Burnie A.G. (1991). Purulent pericarditis in a puppy. Journal of Small Animal Practice 32(11), 585-588.
Garden O.A., Kidd L., Mexas A.M., Chang Y.M., Jeffery U., Blois S.L., Szladovits B. (2019). ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats. Journal of Veterinary Internal Medicine 33(2), 313-334.
Goggs R. (2020). Therapeutic strategies for treatment of immune-mediated hemolytic anemia. Veterinary Clinics: Small Animal Practice 50(6), 1327-1349.
Grundy S.A., Barton C. (2001). Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989–1999). Journal of the American Veterinary Medical Association 218(4), 543-546.
High E.J., Olivry T. (2020). The prevalence of bacterial infections during cyclosporine therapy in dogs: A critically appraised topic. The Canadian Veterinary Journal 61(12), 1283.
Horgan J.E., Roberts B.K., Schermerhorn T. (2009). Splenectomy as an adjunctive treatment for dogs with immune-mediated hemolytic anemia: ten cases (2003–2006). Journal of Veterinary Emergency and Critical Care 19(3), 254-261.
Kellerman D.L., Bruyette D.S. (1997). Intravenous human immunoglobulin for the treatment of immune-mediated hemolytic anemia in 13 dogs. Journal of Veterinary Internal Medicine 11(6), 327-332.
Kemming G., Messick J.B., Mueller W., Enders G., Meisner F., Muenzing, S., Thein, E. (2004). Can we continue research in splenectomized dogs? Mycoplasma haemocanis: old problem–new insight. European Surgical Research 36(4), 198-205.
Kidd L., Mackman N. (2013). Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated hemolytic anemia. Journal of Veterinary Emergency and Critical Care 23(1), 3-13.
Latif A., Patel A.D., Mahfood Haddad T., Lokhande C., Del Core M., Esterbrooks, D. (2020). Massive purulent pericarditis presenting as cardiac tamponade. Baylor University Medical Center Proceedings 33(4), 662-663.
Mohri T., Takashima K., Yamane T., Sato H., Yamane Y. (2009). Purulent pericarditis in a dog administered immune-suppressing drugs. Journal of Veterinary Medical Science 71(5), 669-672.
Morishita K., Sugawara M., Yamazaki J., Kim S., Hosoya K., Sasaki N., Takiguchi M. (2022). Evaluation of the therapeutic efficacy of splenectomy in 20 dogs with non-regenerative immune-mediated anemia. In: Proceedings of the ACVIM forum 2022, June 23-25, Austin, Texas.
Pascutti K.M., Dolan J.K., Porter L.T., Gilor S., Harris A.N. (2022). Case Report: Septic pericarditis with Achromobacter xyloxidans in an immunosuppressed dog. Frontiers in Veterinary Science 9, 1-6.
Sato M., Veir J.K., Legare M., Lappin M.R. (2017). A retrospective study on the safety and efficacy of leflunomide in dogs. Journal of Veterinary Internal Medicine 31(5), 1502-1507.
Scott-Moncrieff J.C., Reagan W.J., Snyder P.W., Glickman L.T. (1997). Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia. Journal of the American Veterinary Medical Association 210(11), 1623-1627.
Sheehan N.K., Kellihan H.B., Yarnall B., Graham M., Moore F. (2019). Septic pericarditis and pericardial abscess secondary to a migrating foreign body in a dog. Journal of Veterinary Cardiology 23, 122-128.
Swann J.W., Skelly B.J. (2013). Systematic review of evidence relating to the treatment of immune-mediated hemolytic anemia in dogs. Journal of Veterinary Internal Medicine 27(1), 1-9.
Swann J.W., Skelly B.J. (2016). Canine autoimmune hemolytic anemia: management challenges. Veterinary Medicine: Research and Reports 7, 101.
Swann J.W., Garden O.A., Fellman C.L., Glanemann B., Goggs R., LeVine D.N., Whitley N.T. (2019). ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs. Journal of Veterinary Internal Medicine 33(3), 1141-1172.
Thomas W.P., Reed J.R., Bauer T.G., Breznock E.M. (1984). Constrictive pericardial disease in the dog. Journal of the American Veterinary Medical Association 184(5), 546-553.
Trotta M., Carli E., Novari G., Furlanello T., Solano-Gallego L. (2009). Clinicopathological findings, molecular detection and characterization of Babesia gibsoni infection in a sick dog from Italy. Veterinary Parasitology 165(3-4), 318-322.
Tseng J.R., Lee M.J., Lin J.L., Yen T.H. (2010). Definite and probable septic pericarditis in hemodialysis. Renal Failure 32(10), 1177-1182.
Veloso G.F., Manteiga E.F., Trehy M., Freeman A., McConnell J.F., McEwan J.D. (2014). Septic pericarditis and myocardial abscess in an English Springer spaniel. Journal of Veterinary Cardiology 16(1), 39-44.
Weinkle T.K., Center S.A., Randolph J.F., Warner K.L., Barr S.C., Erb H.N. (2005). Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993–2002). Journal of the American Veterinary Medical Association 226(11), 1869-1880.
Whelan M.F., O’Toole T.E., Chan D.L., Rozanski E.A., DeLaforcade A.M., Crawford S.L., Cotter S.M. (2009). Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia. Journal of Veterinary Emergency and Critical Care 19(2), 158-164.
